Table 4.
Evaluation of the quality of evidence PEDro scale.
| Authors | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammar A et al. | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 6/10 |
| Da Silva LA et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 7/10 |
| Leonardo-Mendonςa R et al. | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 7/10 |
| McLeay Y et al. | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8/10 |
| Ortiz-Franco M et al. | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 8/10 |
| Sarmiento A et al. | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8/10 |
| Zhang T et al. | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 7/10 |
PEDro items: (1) Eligibility criteria; (2) Random allocation; (3) Concealed allocation; (4) Comparability at baseline; (5) Patient blinding; (6) Therapist blinding; (7) Assessor blinding; (8) At least 85% follow-up; (9) Intention to treat analysis; (10) Between-group statistical comparisons; (11) Point measures and measures of variability.